Posts tagged with: "Enlarged-Board-of-Appeal"
Results 961 - 980
of 1,196
Sorted by Relevance
|
Sort by Date
7 Sep 2015, 1:02 pm
Never too late 59 [week ending on Sunday 16 August] - Fundamental deficiency in an EPO decision need not be a problem |Benedict Cumberbatch versus admiring audience | Emma Perot on graffiti as dress art | Location of London's division of the UPC | Cool, confident and healthy: Katonomy meets Jawbone and Fitbit |Planning permission and that London UPC venue |Partial priority and poisonous provisionals: questions for EPO Enlarged… [read post]
24 Sep 2020, 12:38 pm
A claim is “enlarg[ed]” if it covers any embodiments not covered by any original claim. [read post]
23 Oct 2012, 1:54 am
It can be reconsidered by the Central Reexamination Division itself, and the last decision by that division can be appealed to the Patent Trial and Appeal Board (PTAB), which used to be called the Board of Patent Appeals and Interferences (BPAI) until recently and is like an USPTO-internal appeals court. [read post]
19 Feb 2011, 11:00 am
This decision deals with an appeal filed by the patent proprietor against the revocation of its patent by the Opposition Division (OD). [read post]
25 Jun 2008, 4:33 am
EPO spokesman Rainer Osterwalder said he expected the board to rule before Europe's summer holidays.(...)One of the main reasons for the EPO refusal was that the method used a human embryo which was destroyed in the process.Justin Turner, the lawyer for WARF, told EPO's supreme judiciary body, the seven-member Enlarged Board of Appeal, "There are no grounds whatever to deny a patent for embryonal stem cells. [read post]
20 Oct 2017, 12:21 pm
A 7-4 of the en banc decision of the Federal Circuit concludes that the Patent Trial and Appeal Board improperly requires a patent owner in an inter partes review (IPR) to show that proposed amended patent claims are patentable before a motion to amend those claims will be granted, In an unusually opinion, the deeply divided the Court produced five opinions, none of which had enough backers to constitute the opinion of the Court. [read post]
28 Mar 2011, 1:46 am
For the G 3/08 referral to the Enlarged Board of Appeal of the EPO (see resources here and here), for example, ITechLaw's IP Committee took in an amicus curiae brief the balancing position that the related uncertainty, which extends beyond just the EPO to the national courts dealing with European patents, needs to be clarified: Irrespective of on which side of the debate one stands, there is a definite need for the issue of software patentability to be clarified and… [read post]
21 Sep 2022, 3:54 pm
The reviewing board affirmed, and the claimant appealed. [read post]
29 Mar 2012, 1:10 am
Additionally, should the Patentee scramble to file a preliminary response and fail to persuade the Patent Trial & Appeal Board (PTAB) to deny the petition, once instituted, the third party may be permitted to file a supplemental response (42.123). [read post]
20 Feb 2009, 3:31 am
It reflects an update in the Office's practice to take account of the recent WARF decision [briefly noted by the IPKat here] from the European Patent Office Enlarged Board of Appeal (EBoA), which has addressed the patentabilty of human embryonic stem cell cultures. [read post]
15 Nov 2009, 7:21 am
The stakes are high - the ruling could make or break a lot of biotech applications claiming the use of human stem cells.If all this sounds vaguely familiar to IPKat readers - well, it is; the EPO's Enlarged Board of Appeal last November ruled on a similar question and revoked a patent describing a method for obtaining embryonic stem cell cultures from primates, including humans, filed by the Wisconsin Alumni Research Foundation (WARF) in 1995, because it involved the… [read post]
13 Nov 2011, 5:01 pm
The Enlarged Board of Appeal states in point [2.5.2] of the reasons that if a claim comprises “non-working” embodiments this may have different consequences with regard to the fulfilment of the requirements of A 83, depending on the circumstances. [read post]
17 Oct 2023, 3:40 pm
For sufficiency of second medical indication claims, the Enlarged Board in para 77 of G2/21 formulated a different test than the one formulated in paragraph II of the order. [read post]
1 Aug 2011, 3:01 pm
The opponent filed an appeal against the decision of the Opposition to maintain the patent in amended form.Claim 1 as granted read :1. [read post]
2 Apr 2012, 10:22 pm
If the '403 patent had been challenged e.g. in an opposition the EPO would have been bound to follow established case law and hold that the claimed method was patent-eligible firstly because it is carried out on a sample from the subject and secondly because an in vitro measurement is made, see the Enlarged Appeal Board decision in G 3/08 PRESIDENT'S REFERENCE in which the long-standing practice of the Appeal Boards was approved. [read post]
23 May 2010, 11:36 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: Enlarged Board of Appeal decides on computer-implemented inventions: G0003/08 (Innovation Partners) (IPEG) (EPLAW) Another issue headed for en banc review by the Federal Circuit: How to assess redesigned products: TiVo v. [read post]
1 Sep 2010, 3:02 pm
In the board’s view, this interpretation is in accordance with the general principles concerning opposition proceedings as set out by the Enlarged Board of Appeal (EBA). [read post]
5 Aug 2012, 5:01 pm
As only an abridged version of decision G 1/08 was published, reference will be made hereinafter to decision G 2/07 which was published in its entirety. [18] [Opponent 3] argues that, in accordance with the “whole content approach” developed by the Enlarged Board of Appeal (EBA) in decision G 2/06 [22], not the explicit wording of claim 1 but the technical teaching of the patent as a whole should be taken into consideration for a correct assessment of whether… [read post]
6 Nov 2011, 5:01 pm
The applicant appealed against the decision of the Examining Division (ED) refusing the application under consideration. [read post]
19 Oct 2011, 4:24 am
The fact that destruction may occur at a stage long before the implementation of the invention, as in the case of the production of embryonic stem cells from a lineage of stem cells the mere production of which implied the destruction of human embryos is, in that regard, irrelevant.50 Not to include in the scope of the exclusion from patentability set out in Article 6(2)(c) of the Directive technical teaching claimed, on the ground that it does not refer to the use, implying their prior… [read post]
